Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk hispanic families

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 8, 2007, Pages 1615-1620

  Weitzel, Jeffrey N ^a   Lagos, Veronica I ^a   Herzog, Josef S ^a   Judkins, Thaddeus ^b   Hendrickson, Brant ^b,d   Ho, Jason S ^a   Ricker, Charité N ^a,e   Lowstuter, Katrina J ^a   Blazer, Kathleen R ^a   Tomlinson, Gail ^c   Scholl, Tom ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Myriad Genetic Laboratories   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d GENZYME CORPORATION   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; COMPLEMENTARY DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; DNA DETERMINATION; EXON; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; HAPLOTYPE; HIGH RISK POPULATION; HISPANIC; HUMAN; LYMPHOBLASTOID CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; AFRICAN AMERICANS; AGED; ALTERNATIVE SPLICING; BASE SEQUENCE; BREAST NEOPLASMS; CLONING, MOLECULAR; CODON, TERMINATOR; COHORT STUDIES; DNA BREAKS; EXONS; FEMALE; FOUNDER EFFECT; FRAMESHIFT MUTATION; GENE REARRANGEMENT; GENES, BRCA1; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; INTRONS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; SEQUENCE DELETION;

EID: 34548076029     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0198     Document Type: Article

References (42)

1. Gad S, Caux-Moncoutier V, Pages-Berhouet S, et al. Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 2002;21:6841-7.
2. Casilli F, Tournier I, Sinilnikova OM, et al. The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 2006;43:e49.
3. Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005;25:415-22.
4. Walsh T, Casadei S, Coats KH, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high riskof breast cancer. JAMA 2006;295:1379-88.
5. Gutierrez-Enriquez S, de La Hoya M, Martinez-Bouzas C, et al. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 2007;103:103-7.
6. de la Hoya M, Gutierrez-Enriquez S, Velasco E, et al. Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer. Clin Chem 2006;52:1480-5.
7. Kolomietz E, Meyn MS, Pandita A, Squire JA. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 2002;35:97-112.
8. Smith TM, Lee MK, Szabo CI, et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996;6:1029-49.
9. Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20:1260-8.
10. Lerman C, Hughes C, Benkendorf JL, et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8:361 -7.
11. Armstrong K, Weber B, Stopfer J, et al. Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. Am J Med Genet A 2003;117:154-60.
12. Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 1999;25:59-66.
13. Hughes C, Gomez-Caminero A, Benkendorf J, et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997;32:51-62.
14. Hughes C, Lerman C, Lustbader E. Ethnic differences in riskpe rception among women at increased riskfor breast cancer. Breast Cancer Res Treat 1996;40:25-35.
15. Weitzel JN, Lagos V, Blazer KR, et al. Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 2005;14:1666-71.
16. Couch F, DeShano ML, Blackwood A, et al. BRCA1 mutations in women attending clinics that evaluate the riskof breast cancer. N Engl J Med 1997;336:1409-15.
17. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-90.
18. Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-58.
19. Shih HA, Couch FJ, Nathanson KL, et al. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 2002;20:994-9.
20. Judkins T, Hendrickson BC, Gonzales D, Eliason K, McCulloch J, Scholl T. Detection of large rearrangement mutations in BRCA1 and BRCA2 in 528 high risk families from North America by quantitative PCR based gene dose analysis. American Society of Human Genetics, 54th Annual Meeting. Toronto, Canada; 2004.
21. Yau SC, Bobrow M, Mathew CG, Abbs SJ. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet 1996;33:550-8.
22. Charbonnier F, Raux G, Wang Q, et al. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 2000;60:2760-3.
23. Hendrickson BC, Judkins T, Kouzmine A, et al. Improved quantitative PCR-based gene dose analysis for the clinical laboratory: Assay design parameters and quality assurance metrics. American Society of Human Genetics 54th Annual Meeting. Toronto, Canada; 2004.
24. Brewer C, Holloway S, Zawalnyski P, Schinzel A, FitzPatrick D. A chromosomal duplication map of malformations: regions of suspected haplo- and triplolethality - and tolerance of segmental aneuploidy - in humans. Am J Hum Genet 1999;64:1702-8.
25. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57.
26. Neuhausen SL, Mazoyer S, Friedman L, et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 1996;58:271-80.
27. Neuhausen SL, Godwin AK, Gershoni-Baruch R, et al. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 1998;62:1381-8.
28. Agata S, Viel A, Puppa LD, et al. Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosomes Cancer 2006;45:791-7.
29. Preisler-Adams S, Schonbuchner I, Fiebig B, Welling B, Dworniczak B, Weber BH. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet 2006;168:44-9.
30. Woodward AM, Davis TA, Silva AG, Kirk JA , Leary JA. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 2005;42:e31.
31. Peixoto A, Salgueiro N, Santos C, et al. BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. Fam Cancer 2006;5:379-87.
32. Puget N, Stoppa-Lyonnet D, Sinilnikova OM, et al. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 1999;59:455-61.
33. Makriyianni I, Hamel N, Ward S, Foulkes WD, Graw S. BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder. J Med Genet 2005;42:e207.
34. Central Intelligence Agency (2007). The world factbook 2006. Retrieved January 8, 2007, from CIA World Factbookweb site (https://cia.gov/cia/ publications/factbook/geos/mx.html).
35. Gorodezky C, Alaez C, Vazquez-Garcia MN, et al. The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 2001;62:979-91.
36. Mendez-Sanchez N, King-Martinez AC, Ramos MH, Pichardo-Bahena R, Uribe M. The Amerindian's genes in the Mexican population are associated with development of gallstone disease. Am J Gastroenterol 2004;99:2166-70.
37. Green LD, Derr JN, Knight A. mtDNA affinities of the peoples of North-Central Mexico. Am J Hum Genet 2000;66:989-98.
38. Cerda-Flores RM, Villalobos-Torres MC, Barrera-Saldana HA, et al. Genetic admixture in three Mexican Mestizo populations based on D1S80 and HLADQA1 loci. Am J Hum Biol 2002;14:257-63.
39. Ziv E, John EM, Choudhry S, et. al. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco bay area. Cancer Epidemiol Biomakers Prev 2006;15:1878-85.
40. Sweeney C, Wolff RK, Byers T, et. al. Genetics admixture among Hispanics and candidate gene polymorphisms: potential for confounding in a breast cancer study? Cancer Epidemiol Biomakers Prev 2007;16:142-50.
41. ACS. Cancer Facts and Figures for Hispanics/Latinos 2003-2005, 8623.00. Atlanta (GA): American Cancer Society; 2003.
42. McKean-Cowdin R, Spencer Feigelson H, Xia LY, et. al. BRCA1 variants in a family study of African-American and Latina women. Hum Genet 2005;116:497-506.